Similar process for us.  We have a formal diversion process, however, already in place that identifies specific behaviors (e.g., waste not done immediately, missed count).  This program was championed by nursing.  We add an additional screening panel to our standard 9-Panel pre-employment.  We use CRL.

 

P.S. No tests we have done for diversion have come up positive since this program began.  We have terminated two people for multiple suspected diversions (diversion indicator 3 times, with or without positive screen).

 

Jennifer Beining, MSN, JD, RN, COHN-S, NE-BC

OhioHealth Employer Services

Phone: 614-566-4917

Jennifer.Beining@OhioHealth.com

OhioHealth.com/EmployerServices

 

cid:image001.jpg@01D02A8C.037D8490

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Yvonne Noel via MCOH-EH
Sent: Tuesday, May 01, 2018 5:34 PM
To: MCOH/EH <mcoh-eh@mylist.net>
Cc: Yvonne Noel <Mary.Noel@childrens.com>
Subject: [EXTERNAL] Re: [MCOH-EH] Suspected fentanyl use

 

WARNING:   This email originated from outside of OhioHealth. Please validate the sender's email address before clicking on links or attachments as they may not be safe. 

Thank you for your great/detailed response.  We have done all this, but the results were negative when it was  expected that it would be positive.  That is the reason I am researching further.

Yvonne

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Weaver, Meredith
Sent: Tuesday, May 01, 2018 1:32 PM
To: 'mcoh-eh@mylist.net'
Subject: Re: [MCOH-EH] Suspected fentanyl use

 

[This email was sent from an external source.]

Responses are below …

 

I would appreciate info on the following questions related to suspected  fentanyl use:

 

·        How would you proceed if an employee was suspected of fentanyl use? It depends on how we become aware of the suspected usage.  If it’s identified through our pharmacy surveillance reports, pharmacy sends the reports to the manager and notifies the manager of potential diversion.  The manager then conducts an investigation and contacts HR if diversion is in fact suspected.  A huddle group is then convened with the department manager and/or director, pharmacy, human resources, and employee health to discuss the facts of the case and develop an action plan.  If testing is warranted, then the manager and human resources meet with the employee to take a statement and let the employee know that he/she will be drug tested.  The employee is then brought to employee health for urine drug testing.  After testing, we arrange safe transportation to get the employee home.  The employee may be suspended pending test results, which can take up to five days. (There are a lot of if/then steps in our process.)

 

·        Would you test urine, saliva or blood? Urine

 

·        Can you provide the information on the screening panel used? It's a separate send out to our vendor and not part of our 10- panel used for pre-employment physicals or suspected impairment testing.  

 

·        Where would the specimen be sent for testing? We utilize an outside vendor  - Medtox.  Our lab is looking into the possibility of testing in house.

 

 

 

Thank you,

 

Yvonne Noel

 

 

 

 

 

 

Yvonne Noel

Interim Manager

Occupational Health and Wellness

O: 214-456-1897

F: 214-456-2665

E:mary.noel@childrens.com

 

 

 

/ Meredith R. Weaver, SPHR, SHRM-SCP

Manager, Employee Health

WVU Medicine

PO Box 8120

Morgantown, WV 26506-8120

Clinic: 304-598-4160

Direct: 304-598-6654 or 7-6654

Fax: 304-598-4957

weaverm@wvumedicine.org

WVUMedicine.org

 

 

-----Original Message-----
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Yvonne Noel via MCOH-EH [*]
Sent: Tuesday, May 1, 2018 12:29 PM
To: MCOH/EH <mcoh-eh@mylist.net>
Cc: Yvonne Noel <Mary.Noel@childrens.com>
Subject: [MCOH-EH] Suspected fentanyl use

 

ATTENTION: This email was generated outside of the WVU Medicine email network.  Do not click links or attachments unless you recognize the sender and know the content is safe.

 

 

 

 

 

 

 

 

 

 

 Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.